Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations

Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 657 shares of common stock to cover income tax withholding obligations upon the vesting of restricted stock units.

Summary

• On December 27, 2024, Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 657 shares of common stock.
• The sale was executed at a price of $4.38 per share.
• The transaction was to cover income tax withholding obligations related to the vesting of 2,187 restricted stock units (RSUs) on December 26, 2024.
• Following the transaction, Bergstrom beneficially owns 520,088 shares of Relay Therapeutics, including 447,790 shares underlying RSUs.

Sentiment

Score: 6

Explanation: The document is neutral in tone and describes a routine transaction. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations when RSUs vest. The sale itself is unlikely to have a significant impact on the stock price, but it's important to monitor insider activity as part of overall due diligence.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant.

Key Dates